Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs145818132 | chr7:105164166 | C/T | 5.12E-5 | 178 | 20.2 | 29.43 | 2.28 | KM Plot |
PCPG | rs145907017 | chr2:176163676 | C/T | 0.000115 | 178 | 25.28 | 28.95 | 6.62 | KM Plot |
PCPG | rs146011609 | chr7:76711321 | T/A | 0.000314 | 172 | 25.67 | 24.53 | 14.57 | KM Plot |
PCPG | rs1460219 | chr2:107252360 | T/C | 0.000212 | 178 | 26.57 | 21.95 | 25.87 | KM Plot |
PCPG | rs146085815 | chr7:105162562 | G/C | 5.12E-5 | 178 | 20.2 | 29.43 | 2.28 | KM Plot |
PCPG | rs146115656 | chr2:118537460 | C/T | 1.64E-5 | 177 | 24.7 | 30.63 | 11.65 | KM Plot |
PCPG | rs146130240 | chr7:105156948 | T/C | 5.12E-5 | 178 | 20.2 | 29.43 | 2.28 | KM Plot |
PCPG | rs146134541 | chr16:89851116 | TGGGGAAGGGGAA/T | 0.000168 | 177 | 25.87 | 20.2 | 36.37 | KM Plot |
PCPG | rs146147416 | chr10:29825948 | T/C | 8.92E-11 | 170 | 25.6 | 25.87 | 10.3 | KM Plot |
PCPG | rs146281019 | chr9:136941188 | C/G | 1.85E-5 | 178 | 25.53 | 21.55 | 28.57 | KM Plot |
PCPG | rs146338188 | chr10:69822884 | ATT/A | 0 | 170 | 25.77 | 21.45 | 2.28 | KM Plot |
PCPG | rs146415319 | chr16:88654953 | ATCCTGTCTC/A | 0.000372 | 175 | 25.47 | 24.35 | 14.47 | KM Plot |
PCPG | rs146569219 | chr16:89916879 | C/CGAG | 0.000185 | 172 | 25.87 | 23.37 | 36.37 | KM Plot |
PCPG | rs146635619 | chr2:118683095 | C/T | 1.6E-5 | 178 | 25.17 | 30.93 | 11.65 | KM Plot |
PCPG | rs146760328 | chr13:114179230 | TTTTA/T | 4.67E-12 | 177 | 24.17 | 30.33 | 3.32 | KM Plot |